The Max Planck Society together with Astra Zeneca and Merck KGaA, Darmstadt, Germany, plans to appoint
Three Independent Junior Group Leaders
in the Chemical Genomics Centre of the Max Planck Society in Dortmund; Germany
The Chemical Genomics Centre (CGC) was established in 2005 by the Max-Planck Society (MPG) as collaboration with several
pharmaceutical companies to address challenging scientific problems, to explore and validate high-risk approaches
and to generate cutting edge precompetitive research which could enable the development of translational science in the
medium to long term. The CGC network interconnects the scientific, infrastructural and institutional strength of well-established
Max-Planck Departments with new research groups bringing in intellectual talent and novel scientific approaches. It has a proven
track record from its first two funding periods (2006-2011; 2012-2017), and will serve as a role model for excellent and fruitful
collaborations between academic research and industry again in the third funding period (2018-2023). (For more information about
the CGC and its track record see www.cgc.mpg.de
During the third funding period of the CGC (2018-2023), three Junior Group Leader positions are available. These include direct access
to fully furnished laboratories and funding to start their independent research group. Candidates that have already gained research
experience, are passionate to realize high-level research projects, and interested to qualify for future Professorships or other scientific
leadership positions are welcome to apply.
Successful candidates will have a strong background in chemical biology, medicinal chemistry, organic chemistry or a related
area as proven by an excellent publication record. Group Leaders usually hold an advanced degree with at least one year post-doctoral
experience. The 5-years contract is for a Group Leader at the Junior Professor level, starting in 2018. Funding will be provided in
collaboration with the CGC of the MPG, Astra Zeneca and Merck KGaA, and includes support for the Group Leader position, Ph.D. students and Post Docs.
The CGC develops novel chemical biology, chemistry and biology and approaches to gain novel insight into biological systems.
The independent groups will focus on a topic of chemical biology, including, but not limited to Noncanonical Functions
of Proteins, Druggability of RNA and RNA-Protein Complexes and Small Molecule Target Deconvolution Strategies.
Ambitious candidates looking to make high-impact discoveries with very attractive research proposals on the chemical biology field are welcomed to apply.
The groups will be located in well-equipped laboratories in the BioMedizinZentrum (BMZ) Dortmund.
The BMZ is situated in the Technische Universität Dortmund Campus where it benefits from a strong collaborative, inter-sectorial network of R&D entities
such as the Max Planck Institute of Molecular Physiology (MPI), the Lead Discovery Center (LDC), the Technische Universität Dortmund (TUDo), the Compound
Management and Screening Center (COMAS),
the Zentrum für Integrierte Wirkstoffforschung (ZIW), and the Faculty of the International Max Planck Research School of Chemical Biology (IMPRS).
Candidates will be invited to submit their application and later upon selection be asked to present their research proposal, in English, at the Max Planck Institute in Dortmund on 24th-25th January; 2018.
The Max-Planck Society is committed to increasing the number of individuals with disabilities in its workforce and therefore
encourages applications from such qualified individuals.
The Max-Planck Society seeks to increase the number of women in those areas where they are underrepresented and therefore explicitly encourages women to apply.
Applications including CV, publication list, research proposal (10 pages maximum), in English, and two
of recommendation should be sent to Debora Bruzzese, e-mail: debora.bruzzese@mpi-dortmund.
, who can also be
contacted for additional information, before November 10th, 2017.